We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

EPIRUS Expands Biosimilar Capabilities Through Acquisition of Bioceros

News   Sep 10, 2015

 
EPIRUS Expands Biosimilar Capabilities Through Acquisition of Bioceros
 
 
 

RELATED ARTICLES

Rockland Immunochemicals, Inc. CSO Opines “Benefits of Polyclonal Antibodies” in Peer-reviewed Article

News

Dr. Carl Ascoli, Chief Science Officer at Rockland, and Dr. Birte Aggeler, Director of Antibody Development at Bio-Techne, have composed a review article on the pros and cons of polyclonal, conventional monoclonal, and recombinant monoclonal antibodies.

READ MORE

Science Fans Challenged Once Again to Create the Ultimate Lego Lab

News

Radleys “Build a Lego Lab” competition is back and aims this year to more outlandish, clever and crazy Lego lab creations than ever before.

READ MORE

A Powerful Approach for Stopping Ebola Outbreaks

News

A one-two punch of powerful antibodies may be the best way to stop Ebola virus. Recent findings suggest new therapies should disable Ebola virus’s infection machinery and spark the patient’s immune system to call in reinforcements.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE